Cargando…

Quantitative serological antibody testing for suspected neuroborreliosis

OBJECTIVE: To assess the importance of serum IgG/IgM antibody titers for the differentiation of Lyme neuroborreliosis (LNB) from its mimics. METHOD: This was a retrospective, cross-sectional study conducted at two German neurological centers. Serological parameters (ELISA or CLIA analysis) and clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Christian, Gielen, Jörg, Röth, Philip, Albrecht, Philipp, Schroeter, Michael, Fink, Gereon R., Wunderlich, Gilbert, Lehmann, Helmar C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184039/
https://www.ncbi.nlm.nih.gov/pubmed/32008071
http://dx.doi.org/10.1007/s00415-020-09721-7
_version_ 1783526536510439424
author Schneider, Christian
Gielen, Jörg
Röth, Philip
Albrecht, Philipp
Schroeter, Michael
Fink, Gereon R.
Wunderlich, Gilbert
Lehmann, Helmar C.
author_facet Schneider, Christian
Gielen, Jörg
Röth, Philip
Albrecht, Philipp
Schroeter, Michael
Fink, Gereon R.
Wunderlich, Gilbert
Lehmann, Helmar C.
author_sort Schneider, Christian
collection PubMed
description OBJECTIVE: To assess the importance of serum IgG/IgM antibody titers for the differentiation of Lyme neuroborreliosis (LNB) from its mimics. METHOD: This was a retrospective, cross-sectional study conducted at two German neurological centers. Serological parameters (ELISA or CLIA analysis) and clinical presentation of 28 patients with definite LNB were compared to those of 36 patients with neurological symptoms mimicking LNB (mimics). Analysis was performed using receiver operating characteristic (ROC) and binary logistic regression. RESULTS: Elevated IgG-titers had a high sensitivity for neuroborreliosis in both centers (0.95 and 1.0). The optimal cutoff-values were set to 26.35 in center A (ELISA), and 64.0 in center B (CLIA). Diagnostic specificity was 0.41 and 0.89 in this constellation. Elevated IgM-titers showed a high diagnostic specificity for a cutoff at 68.10 (A) and 47.95 (B) (0.93 and 0.89). Sensitivity was 0.45 and 0.5. Overall diagnostic accuracy was low in both centers (A: IgG AUC = 0.665, IgM AUC = 0.629; B: IgG AUC = 0.917, IgM AUC = 0.556). In logistic regression of antibody titers and clinical measures, prediction of LNB was significantly better than the “null hypothesis”. Clinical measures showed the highest odds ratio. CONCLUSION: Data show that in addition to the clinical presentation of patients with symptoms suggesting central or peripheral nervous system manifestation, serum IgG- and IgM-titers help to identify LNB-patients. The results should guide physicians counseling patients with suspected LNB about further diagnostic steps and treatment.
format Online
Article
Text
id pubmed-7184039
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71840392020-04-29 Quantitative serological antibody testing for suspected neuroborreliosis Schneider, Christian Gielen, Jörg Röth, Philip Albrecht, Philipp Schroeter, Michael Fink, Gereon R. Wunderlich, Gilbert Lehmann, Helmar C. J Neurol Original Communication OBJECTIVE: To assess the importance of serum IgG/IgM antibody titers for the differentiation of Lyme neuroborreliosis (LNB) from its mimics. METHOD: This was a retrospective, cross-sectional study conducted at two German neurological centers. Serological parameters (ELISA or CLIA analysis) and clinical presentation of 28 patients with definite LNB were compared to those of 36 patients with neurological symptoms mimicking LNB (mimics). Analysis was performed using receiver operating characteristic (ROC) and binary logistic regression. RESULTS: Elevated IgG-titers had a high sensitivity for neuroborreliosis in both centers (0.95 and 1.0). The optimal cutoff-values were set to 26.35 in center A (ELISA), and 64.0 in center B (CLIA). Diagnostic specificity was 0.41 and 0.89 in this constellation. Elevated IgM-titers showed a high diagnostic specificity for a cutoff at 68.10 (A) and 47.95 (B) (0.93 and 0.89). Sensitivity was 0.45 and 0.5. Overall diagnostic accuracy was low in both centers (A: IgG AUC = 0.665, IgM AUC = 0.629; B: IgG AUC = 0.917, IgM AUC = 0.556). In logistic regression of antibody titers and clinical measures, prediction of LNB was significantly better than the “null hypothesis”. Clinical measures showed the highest odds ratio. CONCLUSION: Data show that in addition to the clinical presentation of patients with symptoms suggesting central or peripheral nervous system manifestation, serum IgG- and IgM-titers help to identify LNB-patients. The results should guide physicians counseling patients with suspected LNB about further diagnostic steps and treatment. Springer Berlin Heidelberg 2020-02-01 2020 /pmc/articles/PMC7184039/ /pubmed/32008071 http://dx.doi.org/10.1007/s00415-020-09721-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Communication
Schneider, Christian
Gielen, Jörg
Röth, Philip
Albrecht, Philipp
Schroeter, Michael
Fink, Gereon R.
Wunderlich, Gilbert
Lehmann, Helmar C.
Quantitative serological antibody testing for suspected neuroborreliosis
title Quantitative serological antibody testing for suspected neuroborreliosis
title_full Quantitative serological antibody testing for suspected neuroborreliosis
title_fullStr Quantitative serological antibody testing for suspected neuroborreliosis
title_full_unstemmed Quantitative serological antibody testing for suspected neuroborreliosis
title_short Quantitative serological antibody testing for suspected neuroborreliosis
title_sort quantitative serological antibody testing for suspected neuroborreliosis
topic Original Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184039/
https://www.ncbi.nlm.nih.gov/pubmed/32008071
http://dx.doi.org/10.1007/s00415-020-09721-7
work_keys_str_mv AT schneiderchristian quantitativeserologicalantibodytestingforsuspectedneuroborreliosis
AT gielenjorg quantitativeserologicalantibodytestingforsuspectedneuroborreliosis
AT rothphilip quantitativeserologicalantibodytestingforsuspectedneuroborreliosis
AT albrechtphilipp quantitativeserologicalantibodytestingforsuspectedneuroborreliosis
AT schroetermichael quantitativeserologicalantibodytestingforsuspectedneuroborreliosis
AT finkgereonr quantitativeserologicalantibodytestingforsuspectedneuroborreliosis
AT wunderlichgilbert quantitativeserologicalantibodytestingforsuspectedneuroborreliosis
AT lehmannhelmarc quantitativeserologicalantibodytestingforsuspectedneuroborreliosis